Share Issue News
Discover the latest share issue news. Stay informed about new share offerings, market impacts, investor reactions, and financial strategies. Get updates on how share issues influence company valuations and investment opportunities.
Feb 26, 2026 at 8:15 AM
CACI Announces Proposed Offering of $500 Million of Senior Notes Due 2033
RESTON, Va.--(BUSINESS WIRE)--CACI International Inc (NYSE: CACI), or the Company, announced today that it has commenced an offering (the “Offering”) of $500 million in aggregate principal amount of unsecured senior notes due 2033 (the “notes”). The notes will be issued as part of the same series as the Company’s 6.375% senior notes due 2033 originally issued in June 2025. CACI intends to use the net proceeds from the Offering, together with borrowings under its revolving credit facility, proce...
Feb 25, 2026 at 11:03 PM
Metropolitan Bank Holding Corp. Prices Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Metropolitan Bank Holding Corp. (NYSE: MCB) (the “Company”), the holding company for Metropolitan Commercial Bank (the “Bank”), today announced the pricing of an underwritten public offering of 2,100,000 shares of its common stock at a price of $85.00 per share. The Company also granted the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in connection with the offering. The aggregate gross proceeds of the offering wi...
Feb 25, 2026 at 10:57 PM
Innovex International, Inc. Announces Pricing of Underwritten Offering of 5,750,000 Shares of Common Stock by Selling Stockholders
HOUSTON--(BUSINESS WIRE)--INNOVEX INTERNATIONAL, INC. ANNOUNCES PRICING OF UNDERWRITTEN OFFERING OF 5,750,000 SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS...
Feb 25, 2026 at 10:31 PM
Vir Biotechnology Announces Pricing of Public Offering of Common Stock
SAN FRANCISCO--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR), a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer, today announced the pricing of its underwritten public offering of 17,647,058 shares of its common stock at a price to the public of $8.50 per share. The gross proceeds to Vir Biotechnology from the offering are expected to be $150 million, bef...
Feb 25, 2026 at 5:53 PM
Fortress Value Acquisition Corp. V Announces Pricing of $250 Million Initial Public Offering
NEW YORK--(BUSINESS WIRE)--Fortress Value Acquisition Corp. V (the “Company”), a blank check company sponsored by an affiliate of Fortress Investment Group LLC and formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses, today announced the pricing of its initial public offering of 25,000,000 Class A ordinary shares at a price of $10.00 per share. The Class A ordinary shares will...
Feb 25, 2026 at 4:47 PM
Metropolitan Bank Holding Corp. Launches Public Offering of Common Stock
NEW YORK--(BUSINESS WIRE)--Metropolitan Bank Holding Corp. (NYSE: MCB) (the “Company”), the holding company for Metropolitan Commercial Bank (the “Bank”), today announced it launched an underwritten public offering of $175.0 million of common stock. The Company also expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock sold in connection with the proposed offering. The offering is subject to market and other conditions, and there can...
Feb 25, 2026 at 4:46 PM
Innovex International, Inc. Announces Public Offering of Common Stock by Selling Stockholders
HOUSTON--(BUSINESS WIRE)--Innovex International, Inc. Announces Public Offering of Common Stock by Selling Stockholders...
Feb 25, 2026 at 4:06 PM
LSI Industries Announces Proposed $90 Million Public Offering of Common Stock
CINCINNATI--(BUSINESS WIRE)--LSI Industries Inc. (Nasdaq: LYTS, “LSI” or the “Company”), a leading U.S. based manufacturer of commercial lighting and display solutions, today announced that it intends to offer and sell $90 million of its shares of common stock pursuant to an effective shelf registration statement, subject to market and other conditions. In addition, LSI intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered in...
Feb 25, 2026 at 6:00 AM
Sensei Biotherapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Sensei Biotherapeutics, Inc. (Nasdaq: SNSE) today announced that, effective on February 19, 2026, Sensei’s Board of Directors granted 17 new employees, in the aggregate, options to purchase 2,319,893 shares of the Company’s common stock in connection with their employment, including a grant to Anand Parikh of an option to purchase 1,239,305 shares of the Company’s common stock in connection with his employment as Chief Operating Officer of the Company (collectively, the...
Feb 24, 2026 at 6:23 PM
Reinsurance Group of America Announces Pricing of Subordinated Debentures
ST. LOUIS--(BUSINESS WIRE)--Reinsurance Group of America, Incorporated (NYSE: RGA) (“RGA”) announced today that it has priced an aggregate principal amount of $400,000,000 of 6.375% Fixed-Rate Reset Subordinated Debentures due 2056 (the “2056 Debentures”) pursuant to an underwritten registered public offering (the “Offering”). The 2056 Debentures have a maturity date of September 15, 2056, an issue price of 100.000% and feature a fixed-rate coupon of 6.375%, payable semiannually in arrears. RGA...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.